Designer protein delivery: From natural to engineered affinity-controlled release systems

Area of Science:

• Biochemistry
• Biotechnology
• Drug Delivery

Background:

• Exploiting molecular binding affinities is common in diagnostics and drug development.
• Controlling biomolecule release using these affinities is an emerging strategy.
• Affinity-controlled release leverages reversible noncovalent interactions for sustained protein delivery.

Purpose of the Study:

• To review advances in discovering or designing binding partners for affinity-controlled release.
• To highlight methods for controlling therapeutic protein release from a vehicle.

Main Methods:

• In vitro selection of proteins, peptides, and oligonucleotides (aptamers).
• Directed evolution techniques for optimizing binding partners.
• Computational design approaches to aid in partner discovery.

Main Results:

• Demonstrates the potential of affinity-controlled release as a novel drug delivery system.
• Highlights the role of binding affinity, kinetics, and partner concentration in release modulation.
• Reviews various methods for generating and refining binding partners.

Conclusions:

• Affinity-controlled release offers a distinct mechanism for sustained drug delivery compared to degradation-based systems.
• Advances in molecular selection, evolution, and computational design are crucial for developing effective binding partners.
• This strategy holds promise for future therapeutic protein formulations.